# Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation

> **NCT07458191** · — · RECRUITING · sponsor: **Bosnalijek D.D** · enrollment: 800 (estimated)

## Conditions studied

- Nonvalvular Atrial Fibrillation

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT07458191
- **Lead sponsor:** Bosnalijek D.D
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-09
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07458191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07458191, "Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07458191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*